Genmab A/S Stock

Genmab A/S OCF Margin

The Operating Cash Flow Margin of Genmab A/S (GMAB.CO) as of Jul 21, 2026 is 31.88 %. In the previous year, Operating Cash Flow Margin was 36.10 % — a change of -11.69% (lower).

OCF Margin

31.88 %

YoY

-11.69%

Last updated:

Operating Cash Flow Margin of Genmab A/S is 2026 31.88 % . Operating Cash Flow Margin of Genmab A/S was 2025 36.10 % . It decreases by -11.69% lower compared to the previous year.
Access this data via the Eulerpool API

Genmab A/S Stock analysis

What does Genmab A/S do? Genmab A/S is a Danish biotechnology company specializing in the discovery and development of antibody therapies for cancer and other serious diseases. The company was founded in 1999 and is headquartered in Copenhagen, Denmark. Genmab A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genmab A/S stock

Operating Cash Flow Margin of Genmab A/S is 31.88 % in 2026.

Access this data via the Eulerpool API

Margins — Genmab A/S

All Key Metrics — Genmab A/S